Cook Group Incorporated
94
3
3
70
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
14.9%
14 terminated/withdrawn out of 94 trials
83.3%
-3.2% vs industry average
3%
3 trials in Phase 3/4
33%
23 of 70 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (94)
Evaluation of Visceral Function Following Endovascular Aortic Aneurysm Repair Using Branched Stent- Grafts
Role: collaborator
Complex Abdominal Aortic Aneurysm Repair With Fenestrated Stent Grafts
Role: collaborator
Evaluation of the Cook Custom Aortic Endograft, the Zenith t-Branch Endovascular Graft, and Surgeon-Modified Endograft in Treating Aortic Pathologies
Role: collaborator
Bleeding Reduction in Grade II-III Haemorrhoids Through Embolization Treatment
Role: collaborator
Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
Role: collaborator
Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses
Role: lead
Nasal Septal Flap for Donor Site Reconstruction
Role: collaborator
Zenith® TXD Post-market Surveillance in Japan
Role: lead
Evaluation of the Zilver Vascular Stent in the Iliac Arteries (ZIPS)
Role: lead
Prospective Study Evaluating the Feasibility of Fiducial Markers Placement for Patients With Esophageal or Rectal Cancer
Role: collaborator
VascTrac Peripheral Arterial Disease (PAD) Study
Role: collaborator
Removal of the Evolution® Esophageal Stent - Fully Covered
Role: lead
Predicting the Safety and Effectiveness of Inferior Vena Cava Filters
Role: collaborator
Multi-center:The Small (14F) Percutaneous Catheter vs. Large (28-40F) Open Chest Tube for Traumatic Hemothorax (P-CAT)
Role: collaborator
Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer.
Role: collaborator
Tibiopedal Access for Crossing of Infrainguinal Artery Occlusions
Role: lead
Evaluation of CRB in PROM Patients
Role: lead
Zenith® p-Branch™: Single-Center Study
Role: lead
Post-market Observational Study Zenith® t-Branch™
Role: lead
Zenith® TX2® Low Profile TAA Endovascular Graft
Role: lead